- Nachrichtendetail
-
24.06.2024 08:07:05 - dpa-AFX: *GSK: EMA ACCEPTS JEMPERLI+ CHEMOTHERAPY APPLICATION FOR REVIEW TO EXPAND USE FOR PATIENTS WITH ENDOMETRIAL CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
GSK PLC LS-,3125 | A3DMB5 | Frankfurt | 17,710 | 03.07.24 21:49:57 | +0,105 | +0,60% | 0,000 | 0,000 | 17,625 | 17,605 |
